IMNM
Price
$20.78
Change
+$0.64 (+3.18%)
Updated
Jan 14, 04:59 PM (EDT)
Capitalization
2.22B
63 days until earnings call
Intraday BUY SELL Signals
PRLD
Price
$2.25
Change
+$0.01 (+0.45%)
Updated
Jan 14, 04:59 PM (EDT)
Capitalization
142.08M
62 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

IMNM vs PRLD

Header iconIMNM vs PRLD Comparison
Open Charts IMNM vs PRLDBanner chart's image
Immunome
Price$20.78
Change+$0.64 (+3.18%)
Volume$46.72K
Capitalization2.22B
Prelude Therapeutics
Price$2.25
Change+$0.01 (+0.45%)
Volume$6.9K
Capitalization142.08M
IMNM vs PRLD Comparison Chart in %
IMNM
Daily Signal:
Gain/Loss:
PRLD
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
IMNM vs. PRLD commentary
Jan 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMNM is a Hold and PRLD is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 15, 2026
Stock price -- (IMNM: $20.76 vs. PRLD: $2.26)
Brand notoriety: IMNM and PRLD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMNM: 124% vs. PRLD: 62%
Market capitalization -- IMNM: $2.29B vs. PRLD: $142.08M
IMNM [@Biotechnology] is valued at $2.29B. PRLD’s [@Biotechnology] market capitalization is $142.08M. The market cap for tickers in the [@Biotechnology] industry ranges from $114.05B to $0. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMNM’s FA Score shows that 0 FA rating(s) are green whilePRLD’s FA Score has 1 green FA rating(s).

  • IMNM’s FA Score: 0 green, 5 red.
  • PRLD’s FA Score: 1 green, 4 red.
According to our system of comparison, PRLD is a better buy in the long-term than IMNM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMNM’s TA Score shows that 3 TA indicator(s) are bullish while PRLD’s TA Score has 5 bullish TA indicator(s).

  • IMNM’s TA Score: 3 bullish, 5 bearish.
  • PRLD’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, PRLD is a better buy in the short-term than IMNM.

Price Growth

IMNM (@Biotechnology) experienced а +3.90% price change this week, while PRLD (@Biotechnology) price change was -20.14% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.47%. For the same industry, the average monthly price growth was +3.44%, and the average quarterly price growth was +44.89%.

Reported Earning Dates

IMNM is expected to report earnings on Mar 19, 2026.

PRLD is expected to report earnings on Mar 18, 2026.

Industries' Descriptions

@Biotechnology (+0.47% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMNM($2.22B) has a higher market cap than PRLD($142M). IMNM YTD gains are higher at: -6.238 vs. PRLD (-22.759). PRLD has higher annual earnings (EBITDA): -119.27M vs. IMNM (-231.45M). IMNM has more cash in the bank: 273M vs. PRLD (55M). IMNM has less debt than PRLD: IMNM (4.01M) vs PRLD (17.9M). PRLD has higher revenues than IMNM: PRLD (10.5M) vs IMNM (9.68M).
IMNMPRLDIMNM / PRLD
Capitalization2.22B142M1,565%
EBITDA-231.45M-119.27M194%
Gain YTD-6.238-22.75927%
P/E RatioN/AN/A-
Revenue9.68M10.5M92%
Total Cash273M55M496%
Total Debt4.01M17.9M22%
TECHNICAL ANALYSIS
Technical Analysis
IMNMPRLD
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
81%
Momentum
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
88%
MACD
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 6 days ago
83%
Bullish Trend 8 days ago
88%
Declines
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
IMNM
Daily Signal:
Gain/Loss:
PRLD
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ABLOX22.94-0.02
-0.09%
Alger Balanced I-2
SNTKX27.41-0.03
-0.11%
Steward Values Enhanced International A
BRXRX17.49-0.04
-0.23%
MFS Blended Research Intl Eq R1
LCCAX38.67-0.20
-0.51%
Columbia Contrarian Core A
MWOGX48.09-0.37
-0.76%
MFS Global Growth R1

IMNM and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMNM has been loosely correlated with KURA. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if IMNM jumps, then KURA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMNM
1D Price
Change %
IMNM100%
-2.09%
KURA - IMNM
53%
Loosely correlated
+0.44%
VYGR - IMNM
52%
Loosely correlated
+3.08%
IDYA - IMNM
52%
Loosely correlated
-4.75%
NRIX - IMNM
52%
Loosely correlated
+2.99%
RLAY - IMNM
51%
Loosely correlated
+1.79%
More

PRLD and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRLD has been loosely correlated with NAUT. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if PRLD jumps, then NAUT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRLD
1D Price
Change %
PRLD100%
+1.82%
NAUT - PRLD
49%
Loosely correlated
-1.51%
MLTX - PRLD
35%
Loosely correlated
-5.47%
AMRN - PRLD
35%
Loosely correlated
-2.57%
AXON - PRLD
35%
Loosely correlated
+1.55%
IMNM - PRLD
34%
Loosely correlated
-2.09%
More